Fever & Pain
Barif Tablet 40mg
Out of Stock
Call for price
<h2> </h2><p>10 tablets</p><p>Indication:</p><p>BarifTM is indicated for the chronic management of hyperuricemia in patients with gout. BarifTM is not recommended for the</p><p>treatment of asymptomatic hyperuricemia.</p><p>Dosage & Administration:</p><p>BarifTM is recommended at 40 mg or 80 mg once daily. The recommended starting dose of Barif? is 40 mg once daily. For patients who</p><p>do not achieve a serum uric acid less than 6 mg /dL after 2 weeks with 40 mg, BarifTM 80 mg is recommended.</p><p>BarifTM can be administered without regard to food or antacid use. No dose adjustment is necessary when administering Febuxostat</p><p>to patients with mild to moderate renal or hepatic impairment.</p><p>Preparation:</p><p>BarifTM: Each box contains 30 tablets.</p>
10 tablets
Indication:
BarifTM is indicated for the chronic management of hyperuricemia in patients with gout. BarifTM is not recommended for the
treatment of asymptomatic hyperuricemia.
Dosage & Administration:
BarifTM is recommended at 40 mg or 80 mg once daily. The recommended starting dose of Barif? is 40 mg once daily. For patients who
do not achieve a serum uric acid less than 6 mg /dL after 2 weeks with 40 mg, BarifTM 80 mg is recommended.
BarifTM can be administered without regard to food or antacid use. No dose adjustment is necessary when administering Febuxostat
to patients with mild to moderate renal or hepatic impairment.
Preparation:
BarifTM: Each box contains 30 tablets.
No additional specifications available.
No vendor information available.
Related Products
Call for price
Call for price
Call for price
Call for price
Call for price
Call for price
Call for price
Call for price
Call for price
Call for price